Please wait

    Exhibit 107

Calculation of Filing Fee Tables

Form S-8
(Form Type)
Werewolf Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered (1)

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Equity

Common Stock, $0.0001 par value per share

Other

2,241,357 shares (2)

$1.12 (3)

$2,510,319.84 (3)

$153.10 per $1,000,000

$384.33

Equity

Common Stock, $0.0001 par value per share

Other

224,135 shares (4)

$0.95 (5)

$212,928.25 (5)

$153.10 per $1,000,000

$32.60

Total Offering Amounts

$2,723,248.09

$416.93

Total Fee Offsets

$0

Net Fee Due

$416.93

(1)			In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2)			Represents 2,241,357 additional shares of Common Stock reserved for issuance under the 2021 Stock Incentive Plan pursuant to the evergreen provision of such plan.

(3)			Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Global Select Market on March 4, 2025.

(4)			Represents 224,135 additional shares of Common Stock reserved for issuance under the 2021 Employee Stock Purchase Plan pursuant to the evergreen provision of such plan.

(5)			Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Global Select Market on March 4, 2025, multiplied by 85%, which is the percentage of the trading price per share applicable to purchasers under the 2021 Employee Stock Purchase Plan.